Form 4 Filing for BridgeBio Oncology Therapeutics, Inc.

This filing is a Form 4 for BridgeBio Oncology Therapeutics, Inc. (BBOT), reporting changes in beneficial ownership of securities. The reporting owner is FRANK MCCORMICK, who is a director. The filing details the grant of a stock option to purchase 31,675 shares of Common Stock at an exercise price of $7.73 per share. The option has an exercise date tied to a footnote regarding vesting conditions and an expiration date of June 15, 2036. The transaction date was June 16, 2026. The filing also includes an exhibit with a Limited Power of Attorney, appointing attorneys-in-fact to execute SEC filings on behalf of Mr. McCormick, including Forms 3, 4, and 5, and Schedules 13D and 13G. This power of attorney remains in effect until Mr. McCormick is no longer required to file such forms or until earlier revoked.